|
|
||||||||
Journal of Lipid Research, Vol 35, 1232-1240, Copyright © 1994 by Lipid Research, Inc.
ARTICLES |
AG Rosenwald and RE Pagano
Department of Embryology, Carnegie Institution of Washington, Baltimore, MD 21210.
The glucosphingolipid synthesis inhibitor, 1-phenyl-2-decanoylamino-3- morpholino-1-propanol (PDMP) has a wide range of effects on cell physiology and morphology. Here, we studied the effects of high concentrations of PDMP on cells in culture and found that fluorescent analogs of PDMP targeted to the lysosomes of Chinese hamster ovary (CHO) cells. Overnight incubation of the cells in the presence of drug induced enlargement ("vacuolization") of the lysosomes. PDMP was toxic at high concentrations (> 30 microM); this finding was used to select CHO cells that exhibited increased resistance to PDMP (PDMPR cells). The PDMPR cells were approximately 2-fold more resistant to PDMP than the parental cells (CHO-P). PDMPR cells were resistant to a number of other drugs that are also lipophilic and possess a titratable amino group. The multidrug resistance exhibited by the PDMPR cells was distinct from that observed in cells (MDR cells) that overproduce the plasma membrane drug pump, P-glycoprotein. In addition, MDR cells were extremely sensitive to PDMP.
This article has been cited by other articles:
![]() |
I. Y. Tamboli, K. Prager, E. Barth, M. Heneka, K. Sandhoff, and J. Walter Inhibition of Glycosphingolipid Biosynthesis Reduces Secretion of the {beta}-Amyloid Precursor Protein and Amyloid {beta}-Peptide J. Biol. Chem., July 29, 2005; 280(30): 28110 - 28117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. LIU, T.-Y. HAN, A. E. GIULIANO, and M. C. CABOT Ceramide glycosylation potentiates cellular multidrug resistance FASEB J, March 1, 2001; 15(3): 719 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kok, T. Babia, C. M. Filipeanu, A. Nelemans, G. Egea, and D. Hoekstra PDMP Blocks Brefeldin A-induced Retrograde Membrane Transport from Golgi to ER: Evidence for Involvement of Calcium Homeostasis and Dissociation from Sphingolipid Metabolism J. Cell Biol., July 13, 1998; 142(1): 25 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lavie, H.-t. Cao, A. Volner, A. Lucci, T.-Y. Han, V. Geffen, A. E. Giuliano, and M. C. Cabot Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells J. Biol. Chem., January 17, 1997; 272(3): 1682 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Sando, E. J. Howard, and K. C. Madison Induction of Ceramide Glucosyltransferase Activity in Cultured Human Keratinocytes. CORRELATION WITH CULTURE DIFFERENTIATION J. Biol. Chem., September 6, 1996; 271(36): 22044 - 22051. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |